SANTA FE, N.M., Nov. 20 /PRNewswire/ -- Bioreason, Inc. and CTC Laboratory Systems Corporation of Japan announced today the signing of a distribution agreement for exclusive marketing and support of Bioreason's ClassPharmer(TM) systems and databases in Japan. The Bioreason technology is well-established in the US and Europe as a solution for analysis of complex high-throughput, optimization, and ADME/Tox data for discovery. Bioreason's unique automated reasoning approach takes the solutions beyond statistical compilation of data and into the realm of decision-support and guidance to optimizing the path to new products.
Mr. Michael Grantham, CEO of Bioreason, said, "We are pleased to welcome the excellent team at CTC into our sales and support effort, and look forward to increasing our base of users in Japan."
Mr. Taizo Watanabe, President of CTC Laboratory Systems Corporation, said, "The Bioreason systems and databases are a key addition to the range of technology products that our customers in Japan demand. We are excited about bringing this offering to our customers and satisfying the demand there for increasing the productivity and reliability of decision-making in discovery."
Bioreason, Inc. will be providing the latest version releases to CTC Laboratory Systems for sales directly to pharmaceutical, biotech, and discovery products industries throughout Japan. Front-line support will be provided through the CTC offices in Tokyo, with back-line support provided through the Bioreason corporate offices in Santa Fe, New Mexico. User group meetings in Tokyo and Osaka are planned for early next year.
CTC Laboratory Systems Corporation (Tokyo, Japan), a subsidiary of ITOCHU TECHNO-SCIENCE Corporation, is Japan's leading provider of total information technology solutions for pharmaceutical, chemical, and food processing industries, as well as life sciences research institutions. Additional information on CTC can be found at http://www.ctc-g.co.jp/ .
Bioreason, Inc., is headquartered in Santa Fe, New Mexico, with sales and support offices in Strasbourg (France) and Michigan, and with sales and support representation in Tokyo. Bioreason provides knowledge-based software, services, and collaborations that automate reasoning with complex data in the drug discovery process. For information on the company, see http://www.bioreason.com/ .